Volume 20, Number 4—April 2014
Research
Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
Table 3
Collection |
No. BCoV positive/no. MERS-CoV positive (serum dilution, %) |
|
640–1,280 |
>1,280 |
|
1A | 15/74 (20.3) | 14/79 (17.7) |
1B | 0 | 0 |
2 | 0/3 (0.0) | 14/42 (33.3) |
3 | 2/13 (15.4) | 52/182 (28.6) |
4 |
6/30 (20.0) |
14/86 (16.3) |
Total | 23/120 (19.2) | 94/389 (24.2) |
*BCoV, bovine coronavirus; MERS-CoV, Middle East respiratory syndrome coronavirus.
Page created: March 12, 2014
Page updated: March 12, 2014
Page reviewed: March 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.